Chembio Diagnostics Inc. (CEMI) Fundamentals

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
SHARE INFORMATION
Market Cap$ 32,639,608
Shares Outstanding30,221,859
Float29,794,308
Percent Float98.59%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 36,926,726
Latest Fiscal EPS$ -1.42
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions111
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months13,788
Institutional Holdings Percent17.9%
Institutional Sold Previous 3 Months3,015,921
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months219,429
Insider Holdings Percent7.8
Insider Sold Previous 3 Months-
Insider Shares Owned2,347,911
TRADING INFO
52 Week High$ 3.75
52 Week Low$ 0.42
52 Week High Change$ -68.42
21 Day Moving Average$ 0.7812
21 Day Extended Moving Average$ 0.775717
50 Day Moving Average$ 0.7234
50 Day Extended Moving Average$ 0.740657
200 Day Moving Average$ 1.0931
200 Day Extended Moving Average$ 1.2406
10 Day Average Volume3,647,539
20 Day Average Volume1,872,596
30 Day Average Volume1,281,509
50 Day Average Volume848,596
Alpha-0.018924
Beta1.6449
Standard Deviation0.287156
R20.082089
7 Day Price Change$ 0.4024
7 Day Percent Change59.39%
21 Day Price Change$ 0.2854
21 Day Percent Change35.92%
30 Day Price Change$ 0.4447
30 Day Percent Change70.0%
Month to Date Price Change$ 0.39
Month to Date Percent Change56.52%
Quarter to Date Price Change$ 0.43
Quarter to Date Percent Change66.15%
180 Day Price Change$ 0.0803
180 Day Percent Change8.03%
200 Day Price Change$ -0.01
200 Day Percent Change-0.92%
Year to Date Price Change$ -0.06
Year to Date Percent Change-5.26%

Chembio Diagnostics Inc. (CEMI) Key Ratios

PROFITABILITY
EBIT Margin-70.0%
EBITDA Margin-64.3%
Pre-Tax Profit Margin-51.3%
Profit Margin Count-63.55%
Gross Margin8.3%
Profit Margin TOT-63.55%
INCOME STATEMENTS
Revenue$ 46,186,868
Revenue Per Share$ 1.5283
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity1.00
Int Coverage-12.00
Current Ratio3.50
Leverage Ratio2.20
Quick Ratio2.50
Long Term Debt To Capital0.46
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 23,468,742
Price to Sales0.706686
Price to Free Cash-1.10
PE High Last 5 Years-6.50
Price To Book0.80
Price To Cash Flow649.30
PE Low Last 5 Years-9.30
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.10
Invoice Turnover3.50
Assets Turnover0.80
Return Assets-65.23
Return on Equity-157.43
Return on Capital-72.17

Chembio Diagnostics Inc. (CEMI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORichard L. Eberly
Emplyoees337
Last AuditUE
CIK0001092662
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address555 Wireless Boulevard
Hauppauge, NY 11788
Websitehttp://www.chembio.com
Facsimile+1 631 924-2065
Telephone+1 631 924-1135
Emailinvestor@chembio.com


Your Recent History
NASDAQ
CEMI
Chembio Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.